Sal-Acid

Ingredient matches for Sal-Acid

Salicylic Acid

Salicylic Acid is reported as an ingredient of Sal-Acid in the following countries:

• United States

International Drug Name Search

Carbargal

Carbargal may be available in the countries listed below.

Ingredient matches for Carbargal

Charcoal

Charcoal, Activated is reported as an ingredient of Carbargal in the following countries:

• Venezuela

International Drug Name Search

Cobactan LA

Cobactan LA may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Cobactan LA

Cefquinome

Cefquinome sulfate (a derivative of Cefquinome) is reported as an ingredient of Cobactan LA in the following countries:

• Netherlands

International Drug Name Search

Teromol

Teromol may be available in the countries listed below.

Ingredient matches for Teromol

Theophylline

Theophylline is reported as an ingredient of Teromol in the following countries:

• Spain

International Drug Name Search

Doxycyclin TC

Doxycyclin TC may be available in the countries listed below.

Ingredient matches for Doxycyclin TC

Doxycycline

Doxycycline is reported as an ingredient of Doxycyclin TC in the following countries:

• Lithuania

International Drug Name Search

Cefteram

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0082547-58-8

Chemical Formula

C16-H17-N9-O5-S2

Molecular Weight

479

Therapeutic Category

Antibacterial: Cephalosporin

Chemical Name

(+)-(6R,7R)-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 72-(Z)-(O-methyloxime)

Foreign Names

• Cefteramum (Latin)
• Cefteram (German)
• Cefteram (French)
• Cefteram (Spanish)

Generic Names

• Ro 195247 (IS: Roche)
• T 2525 (IS: Toyama)
• Cefteram Pivoxil (OS: JAN)
• Cefteram Pivoxil (PH: JP XV)

Brand Names

• Cetlat
  Sawai Seiyaku, Japan



• Somatron
  Taiyo Pharmaceutical, Japan



• Teracefron
  Nichi-Iko PharmaceuticalJMA, Japan



• Teramiron
  Towa Yakuhin, Japan



• Tomiron
  Taisho Yakuhin, Japan; Toyama, China; Toyama Kagaku, Japan



• Vokicilon
  Choseido Pharmaceutical, Japan

International Drug Name Search

Glossary

IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Oxitropic

Oxitropic may be available in the countries listed below.

Ingredient matches for Oxitropic

Oxaliplatin

Oxaliplatin is reported as an ingredient of Oxitropic in the following countries:

• Spain

International Drug Name Search

Itedal

Itedal may be available in the countries listed below.

Ingredient matches for Itedal

Paracetamol

Paracetamol is reported as an ingredient of Itedal in the following countries:

• Argentina

International Drug Name Search

AK-Sulf

In the US, AK-Sulf (sulfacetamide sodium ophthalmic) is a member of the drug class ophthalmic anti-infectives and is used to treat Conjunctivitis and Trachoma.

US matches:

• AK-Sulf

Ingredient matches for AK-Sulf

Sulfacetamide Sodium

Sulfacetamide sodium salt (a derivative of Sulfacetamide) is reported as an ingredient of AK-Sulf in the following countries:

• Peru


• United States

International Drug Name Search

Citalopram Mylan

Citalopram Mylan may be available in the countries listed below.

Ingredient matches for Citalopram Mylan

Citalopram

Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Citalopram Mylan in the following countries:

• Belgium


• France


• Italy


• Slovakia


• Sweden

Citalopram hydrochloride (a derivative of Citalopram) is reported as an ingredient of Citalopram Mylan in the following countries:

• Italy

International Drug Name Search

Pantocalm

Pantocalm may be available in the countries listed below.

Ingredient matches for Pantocalm

Pantoprazole

Pantoprazole is reported as an ingredient of Pantocalm in the following countries:

• Venezuela

International Drug Name Search

Diclo-Puren

Diclo-Puren may be available in the countries listed below.

Ingredient matches for Diclo-Puren

Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclo-Puren in the following countries:

• Germany

International Drug Name Search

Deoxymykoin

Deoxymykoin may be available in the countries listed below.

Ingredient matches for Deoxymykoin

Doxycycline

Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Deoxymykoin in the following countries:

• Czech Republic


• Slovakia

International Drug Name Search

Mymox

Mymox may be available in the countries listed below.

Ingredient matches for Mymox

Amoxicillin

Amoxicillin is reported as an ingredient of Mymox in the following countries:

• Latvia

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Mymox in the following countries:

• Sri Lanka

International Drug Name Search

Dopamine

In the US, Dopamine (dopamine systemic) is a member of the following drug classes: catecholamines, inotropic agents, vasopressors and is used to treat Nonobstructive Oliguria and Shock.

US matches:

• Dopamine


• Dopamine Hydrochloride


• Dopamine Injection


• Dopamine and Dextrose

UK matches:

• Dopamine 40 mg/ml and 160 mg/ml Sterile Concentrate (Hospira UK Ltd)
• Dopamine 40 mg/ml Sterile Concentrate (SPC)

Scheme

Prop.INN

ATC (Anatomical Therapeutic Chemical Classification)

C01CA04

CAS registry number (Chemical Abstracts Service)

0000051-61-6

Chemical Formula

C8-H11-N-O2

Molecular Weight

153

Therapeutic Categories

Cardiac stimulant, cardiotonic agent

Antihypotensive agent

Chemical Name

1,2-Benzenediol, 4-(2-aminoethyl)-

Foreign Names

• Dopaminum (Latin)
• Dopamin (German)
• Dopamine (French)
• Dopamina (Spanish)

Generic Names

• Dopamina (OS: DCIT)
• Dopamine (OS: BAN, DCF)
• 3-Hydroxytyramin (IS)
• KW 3-060 (IS)
• Dopamine Hydrochloride (OS: BANM, JAN, USAN)
• ASL 279 (IS: DuPont Merck)
• Dopamine (chlorhydrate de) (PH: Ph. Eur. 6)
• Dopamine Hydrochloride (PH: BP 2010, Ph. Eur. 6, Ph. Int. 4, USP 32, JP XV)
• Dopaminhydrochlorid (PH: Ph. Eur. 6)
• Dopamini hydrochloridum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

• Dofaminum Solutio Darnitsa
  Darnitsa, Georgia



• Dopamina
  Sanderson, Peru



• Dopamine Aguettant
  Aguettant, Tunisia



• Dopamine
  Pierre Fabre, Tunisia



• Abbodop
  Hospira, Norway



• Cardiopal
  Biogen, Colombia



• CatabonHi
  Kowa Souyaku, Japan



• CatabonLow
  Kowa Souyaku, Japan



• Cetadop
  Ethica Industri Farmasi, Indonesia



• Clorhidrat de Dopaminã
  Zentiva, Romania



• Clorhidrato Dopamina Grifols
  Grifols, Spain



• Cordodopa Forte
  Winthrop, Portugal



• Critpan
  Asahi Kasei, Japan



• DBL Sterile Dopamine
  Hospira, Australia



• Docard
  Dexxon, Israel



• Dolpamil
  Tobishi, Japan



• Dominin
  Nippon Shinyaku, Japan



• Dopacris
  Cristália, Brazil



• Dopamin Admeda
  Admeda, Hungary; Medicuspharma, Croatia (Hrvatska)



• Dopamin Carino
  Carinopharm, Germany



• Dopamin Ebewe
  Ebewe, Hong Kong; Ebewe, Vietnam



• Dopamin Fresenius
  Fresenius, Bosnia & Herzegowina; Fresenius, Germany; Fresenius Kabi, Austria; Fresenius Kabi, Switzerland; Medias International, Slovenia



• Dopamin Giulini
  Kali, Luxembourg; Solvay, Indonesia



• Dopamin Sintetica
  Sintetica, Switzerland



• Dopamin Solvay
  Solvay, Bulgaria; Solvay, Estonia; Solvay, Georgia; Solvay, Lithuania; Solvay, Latvia; Solvay, Romania



• Dopamin
  Farmakos, Serbia; Nycomed, Norway; Solvay, Poland



• Dopamina Ahimsa
  Ahimsa, Argentina



• Dopamina Biol
  Biol, Argentina



• Dopamina Biologici
  Biologici, Italy



• Dopamina Cloridrato
  Biosano, Chile; Ryan, Colombia; Salf, Italy; Sanderson, Chile; Volta, Chile



• Dopamina Duncan
  Duncan, Argentina



• Dopamina Fabra
  Fabra, Argentina



• Dopamina Fisiopharma
  Fisiopharma, Italy



• Dopamina Galenica
  Galenica, Italy



• Dopamina Hospira
  Hospira, Italy



• Dopamina Northia
  Northia, Argentina



• Dopamina Richmond
  Richmond, Argentina



• Dopamina
  Flupal, Venezuela; Medicalex, Colombia; Pharmakin, Venezuela; Pifano, Venezuela



• Dopamine 200 Pierre Fabre
  Pierre Fabre Médicament, France



• Dopamine 50 Pierre Fabre
  Pierre Fabre Médicament, France



• Dopamine Aguettant
  Aguettant, France



• Dopamine Anfarm
  Anfarm, Greece



• Dopamine Fresenius
  Fresenius, Oman; Fresenius, Turkey



• Dopamine Harvest Pharm
  Harvest Pharm, China



• Dopamine Hcl Abbott
  Abbott, Thailand



• Dopamine HCL DBL
  Hospira, Indonesia; Hospira, Singapore; Mayne, Hong Kong; Tempo Scan Pacific, Indonesia



• Dopamine HCl Demo
  Demo, Greece



• Dopamine HCl Hospira
  Hospira, Indonesia; Transfarma Medica Indah, Indonesia



• Dopamine HCl-Fresenius
  Bodene, South Africa



• Dopamine Hydrochloride in Dextrose
  Baxter, Canada; Baxter, United States; Braun, United States; Hospira, Canada; Hospira, United States; McGaw, United States



• Dopamine Hydrochloride
  American Regent, United States; Hospira, United States; Luitpold, United States; Polfa Warshavskiy, Russian Federation; Polfa Warszawa, Lithuania; Sicor, United States



• Dopamine Mylan
  Mylan, France



• Dopamine Pierre Fabre
  PF, Luxembourg; Pierre Fabre, Bulgaria; Pierre Fabre Médicament, France



• Dopamine Renaudin
  Renaudin, France



• Dopamine
  Antigen, Oman; DBL/Faulding, Bangladesh; Fresenius, Turkey; Hospira, United Kingdom; Hospira, Malta; Hospira, Taiwan; IMS, Oman; Kobayashi Kako, Japan; Towa Yakuhin, Japan; Unimed & Unihealth, Bangladesh



• Dopamin-ratiopharm
  Ratiopharm, Germany



• Dopaminum Hydrochloricum
  Polfa Warszawa, Poland



• Doparalmin
  Nipro PharmaNipurofama, Japan



• Dopatropin
  Scott, Argentina



• Dopina
  Behrens, Venezuela



• Dopinga
  Inga, India



• Dopmin
  Drogsan, Turkey; Orion, United Arab Emirates; Orion, Bahrain; Orion, Denmark; Orion, Estonia; Orion, Egypt; Orion, Finland; Orion, Georgia; Orion, Jordan; Orion, Kuwait; Orion, Lebanon; Orion, Qatar; Orion, Russian Federation; Orion, Thailand; Orion, Yemen



• Dynatra
  Almirall, Belgium; Almirall, Luxembourg; Zambon, Netherlands



• Evetant
  Towa Yakuhin, Japan



• Gabans
  Mylan Pharmaceutical, Japan



• Giludop
  Abcur, Sweden; Pharmaselect, Austria; Pharmaselect, Greece



• Indop
  Fahrenheit, Indonesia



• Inopin
  Siam Bheasach, Thailand



• Inotropin
  Bagó, Argentina



• Inovan
  Kyowa Hakko Kirin, Japan



• Kakodin
  Nihon Seiyaku, Japan



• Kakodin D
  Nihon Seiyaku, Japan



• Martburnl
  Tatsumi Kagaku, Japan



• Medopa
  Medinfar, Portugal



• Megadose
  Fada, Argentina



• Predopa
  Kyowa Hakko Kirin, Japan; Mylan Pharmaceutical, Japan



• Proinfark
  Phapros Tbk, Indonesia



• Revivan
  AstraZeneca, Italy; Zambon, Brazil



• Sterile Dopamin Concentrate
  Hospira, New Zealand; International Medication Systems, United Kingdom



• Tensamin
  Zentiva, Czech Republic; Zentiva, Slovakia



• Tsurudopami
  Tsuruhara Seiyaku, Japan



• Udopa
  Dipa, Indonesia; Korea United, Myanmar; Korea United Pharm, Vietnam



• Yaelista
  Isei, Japan

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Prop.INN	Proposed International Nonproprietary Name (World Health Organization)
SPC	Summary of Product Characteristics (UK)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Cinarizina Ratiopharm

Cinarizina Ratiopharm may be available in the countries listed below.

Ingredient matches for Cinarizina Ratiopharm

Cinnarizine

Cinnarizine is reported as an ingredient of Cinarizina Ratiopharm in the following countries:

• Portugal


• Spain

International Drug Name Search

Diltiangina

Diltiangina may be available in the countries listed below.

Ingredient matches for Diltiangina

Diltiazem

Diltiazem is reported as an ingredient of Diltiangina in the following countries:

• Portugal

International Drug Name Search

Orfro

Generic Name: orphenadrine (Injection route)

or-FEN-a-dreen

Commonly used brand name(s)

In the U.S.

• Antiflex


• Mio-Rel


• Norflex


• Orfro


• Orphenate

Available Dosage Forms:

• Solution

Therapeutic Class: Skeletal Muscle Relaxant, Centrally Acting

Pharmacologic Class: Antimuscarinic

Uses For Orfro

Orphenadrine is used to help relax certain muscles in your body and relieve the stiffness, pain, and discomfort caused by strains, sprains, or other injury to your muscles. However, this medicine does not take the place of rest, exercise or physical therapy, or other treatment that your doctor may recommend for your medical problem .

Orphenadrine acts in the central nervous system (CNS) to produce its muscle relaxant effects .

This medicine is available only with your doctor's prescription .

Before Using Orfro

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of orphenadrine in the pediatric population. Safety and efficacy have not been established .

Geriatric

No information is available on the relationship of age to the effects of orphenadrine in geriatric patients. However, elderly patients are more likely to have age-related heart, liver, or kidney problems which may require caution in patients receiving orphenadrine .

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	C	Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Perphenazine

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:

• Enlarged esophagus or


• Enlarged prostate or


• Glaucoma or


• Intestinal blockage or


• Myasthenia gravis or


• Stomach ulcer or


• Urinary tract blockage—Orphenadrine should not be used in patients with these conditions .

• Heart problems (e.g., fast or irregular heartbeats, heart failure)—Use with caution. Orphenadrine may worsen these conditions .

Proper Use of orphenadrine

This section provides information on the proper use of a number of products that contain orphenadrine. It may not be specific to Orfro. Please read with care.

A nurse or other trained health professional will give you this medicine. This medicine is given through a needle placed in one of your veins or into your muscle .

Precautions While Using Orfro

Your doctor will only give you a few doses of this medicine until your condition improves, and then you will be switched to an oral medicine that works the same way. If you have any concerns about this, talk to your doctor .

Orfro Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur:

Rare

• Cough


• difficulty swallowing


• dizziness


• fast heartbeat


• hives


• itching


• puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue


• shortness of breath


• skin rash


• tightness in chest


• unusual tiredness or weakness


• wheezing

Incidence not known

• Abdominal or stomach pain


• diarrhea


• fast, pounding, or irregular heartbeat or pulse


• fever


• glaucoma


• joint or muscle pain


• nausea


• numbness or tingling of face, hands, or feet


• redness and soreness of eyes


• shortness of breath


• sores in mouth


• swelling of feet or lower legs


• vomiting

Get emergency help immediately if any of the following symptoms of overdose occur:

Symptoms of Overdose

• Blurred vision


• confusion, delirium, or hallucinations


• constipation


• difficult urination


• drowsiness


• dry eyes, mouth, nose, or throat


• eye pain


• flushing or redness of face


• troubled breathing

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

• Anxiety


• deep or fast breathing with dizziness


• headache


• irritability


• itching skin


• mental confusion


• nervousness


• numbness of feet, hands and around mouth


• restlessness


• trembling or shaking of hands or feet shakiness in legs, arms, hands, or feet


• unusually large pupils of eyes


• weakness

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Orfro side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More Orfro resources

• Orfro Side Effects (in more detail)
• Orfro Use in Pregnancy & Breastfeeding
• Orfro Drug Interactions
• Orfro Support Group
• 0 Reviews for Orfro - Add your own review/rating

• Norflex Prescribing Information (FDA)


• Norflex Concise Consumer Information (Cerner Multum)


• Norflex Monograph (AHFS DI)


• Norflex MedFacts Consumer Leaflet (Wolters Kluwer)

Compare Orfro with other medications

• Migraine
• Muscle Spasm

Donepezil Sandoz

Donepezil Sandoz may be available in the countries listed below.

Ingredient matches for Donepezil Sandoz

Donepezil

Donepezil hydrochloride (a derivative of Donepezil) is reported as an ingredient of Donepezil Sandoz in the following countries:

• Slovakia


• Switzerland

International Drug Name Search

Urokinase HS medac

Urokinase HS medac may be available in the countries listed below.

Ingredient matches for Urokinase HS medac

Urokinase

Urokinase is reported as an ingredient of Urokinase HS medac in the following countries:

• Germany


• Switzerland

International Drug Name Search

Distamin

Distamin may be available in the countries listed below.

Ingredient matches for Distamin

Chlorphenamine

Chlorphenamine maleate (a derivative of Chlorphenamine) is reported as an ingredient of Distamin in the following countries:

• Bangladesh

Penicillamine

Penicillamine is reported as an ingredient of Distamin in the following countries:

• India

International Drug Name Search

Nansen

Nansen may be available in the countries listed below.

Ingredient matches for Nansen

Omeprazole

Omeprazole is reported as an ingredient of Nansen in the following countries:

• Italy

International Drug Name Search

Histigo

Histigo may be available in the countries listed below.

Ingredient matches for Histigo

Betahistine

Betahistine dimesilate (a derivative of Betahistine) is reported as an ingredient of Histigo in the following countries:

• Indonesia

International Drug Name Search

Doc Cefuroxime

Doc Cefuroxime may be available in the countries listed below.

Ingredient matches for Doc Cefuroxime

Cefuroxime

Cefuroxime is reported as an ingredient of Doc Cefuroxime in the following countries:

• Luxembourg

International Drug Name Search

PMS-Glyburide

PMS-Glyburide may be available in the countries listed below.

Ingredient matches for PMS-Glyburide

Glibenclamide

Glibenclamide is reported as an ingredient of PMS-Glyburide in the following countries:

• Canada

International Drug Name Search

Theracap 131

Theracap 131 may be available in the countries listed below.

Ingredient matches for Theracap 131

Sodium Iodide

Sodium Iodide is reported as an ingredient of Theracap 131 in the following countries:

• Bulgaria


• Estonia


• Latvia


• Switzerland

Theophylline

Theophylline is reported as an ingredient of Theracap 131 in the following countries:

• Poland

International Drug Name Search

Catenol

Catenol may be available in the countries listed below.

Ingredient matches for Catenol

Atenolol

Atenolol is reported as an ingredient of Catenol in the following countries:

• Ethiopia


• Myanmar

International Drug Name Search

BPO 9 Foaming Cloths

Generic Name: benzoyl peroxide

Dosage Form: cloth
BPO 9 Foaming Cloths

DESCRIPTION: BPO 9% Foaming Cloths are topical preparations containing benzoyl peroxide for use in the treatment of acne vulgaris.Benzoyl peroxide is an oxidizing agent that possesses antibacterial properties and is classified as a keratolytic. Benzoyl peroxide (C14H10O4) is represented by the following chemical structure:

BPO 3% and 6% Foaming Cloths contain, respectively, benzoyl peroxide 3% and 6% as the active ingredient in a cream vehicle containing: cetostearyl alcohol, hydrogenated castor oil, cocamidopropyl betaine, PEG-14M, methyl paraben, mineral oil, purified water, sodium lauryl sulfate, potassium choride, glycolic acid, imidurea, sodium PCA liquid, cornstarch, titanium dioxide, sodium hydroxide, glycerine, dimethyl isosorbide.

CLINICAL PHARMACOLOGY: The mechanism of action of benzoyl peroxide is not totally understood but its antibacterial activity against Propionibacterium acnes is thought to be a major mode of action. In addition, patients treated with benzoyl peroxide show a reduction in lipids and free fatty acids, and mild desquamation (drying and peeling activity) with simultaneous reduction in comedones and acne lesions. Little is known about the percutaneous penetration, metabolism, and excretion of benzoyl peroxide, although it has been shown that benzoyl peroxide absorbed by the skin is metabolized to benzoic acid and then excreted as benzoate in the urine. There is no evidence of systemic toxicity caused by benzoyl peroxide in humans.

INDICATIONS: BPO 9% Foaming Cloths are indicated for the topical treatment of acne vulgaris.

CONTRAINDICATIONS: These preparations are contraindicated in patients with a history of hypersensitivity to any of their components.

WARNINGS: When using this product, avoid unnecessary sun exposure and use a sunscreen.

FOR EXTERNAL USE ONLY. Keep away from eyes. Keep container tightly closed.

Keep out of reach of children.

PRECAUTIONS: General - For external use only. If severe irritation develops, discontinue use and institute appropriate therapy. After reaction clears, treatment may often be resumed with less frequent application. These preparations should not be used in or near the eyes or on mucous membranes.

Information for patients - Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. Contact with any colored material (including hair and fabric) may result in bleaching or discoloration. If excessive irritation develops, discontinue use and consult your physician.

Carcinogenesis, Mutagenesis, Impairment of Fertility - Data from several studies employing a strain of mice that are highly susceptible to developing cancer suggest that benzoyl peroxide acts as a tumor promoter. The clinical significance of these findings to humans is unknown. Benzoyl peroxide has not been found to be mutagenic (Ames Test) and there are no published data indicating it impairs fertility.

PREGNANCY: Teratogenic Effects - Pregnancy Category C. - Animal reproduction studies have not been conducted with benzoyl peroxide. It is not known whether benzoyl peroxide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Benzoyl peroxide should be used by a pregnant woman only if clearly needed. There are no available data on the effect of benzoyl peroxide on the later growth, development and functional maturation of the unborn child.

NURSING MOTHERS: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when benzoyl peroxide is administered to a nursing woman.

PEDIATRIC USE: Safety and effectiveness in children have not been established.

ADVERSE REACTIONS:Allergic contact dermatitis and dryness have been reported with topical benzoyl peroxide therapy.

OVERDOSAGE: If excessive scaling, erythema or edema occurs, the use of these preparations should be discontinued. To hasten resolution of the adverse effects, cool compresses may be used. After symptoms and signs subside, a reduced dosage schedule may be cautiously tried if the reaction is judged to be due to excessive use and not allergenicity.

DOSAGE AND ADMINISTRATION: Wash affected areas once or twice daily, or as directed by your physician. Wet face with water. Wet cloth with a little water and work into a full lather. Cleanse face with cloth for 10–20 seconds. Avoid eyes or mucous membranes. Rinse thoroughly and pat dry.

If drying occurs, it may be controlled by rinsing sooner or using less often. Throw away cloth. Do not flush.

HOW SUPPLIED: BPO 9% Foaming Cloths are available in boxes of 60 cloths (3.2g), (NDC 42192-128-60).

Store at controlled room temperature, 15 degree - 25 degree C (59 degree - 77 degree F).

All prescription substitutions and/or recommendations using this product shall be made subject to state and federal statutes as applicable. NOTE: This is not an Orange Book product and has not been subjected to FDA therapeutic equivalency or other equivalency testing. No representation is made as to generic status or bioequivalency. Each person recommending a prescription substitution using this product shall make such recommendations based on each such person’s professional opinion and knowledge, upon evaluating the active ingredients, excipients, inactive ingredients and chemical formulation information provided herein.

MANUFACTURED FOR: Acella Pharmaceuticals, LLC

9005 Westside Parkway

Alpharetta, GA 30009

1-800-541-4802

NDC 42192-128-60


BPO 9% Foaming Cloths


Rx only


Net weight 3.2 g each


Acella

PHARMACEUTICALS, LLC


Contents: benzoyl peroxide USP 9% as an active ingredient in a cream vehicle containing cetostearyl alcohol, hydrogenated castor oil, cocamidopropyl betaine, PEG-14M, methyl paraben, mineral oil, purified water, sodium lauryl sulfate, potassium choride, glycolic acid, imidurea, sodium PCA liquid, cornstarch, titanium dioxide, sodium hydroxide, glycerine, dimethyl isosorbide.


Directions: Wash affecte areas with BPO 9% Foaming cloths once or twice daily, or as directed by your physician.

1. Wet face with water.

2. Wet cloth with a little water and work into a full lather.

3. Cleanse face wuth cloth for 10 - 20 seconds, avoiding eyes and mucous    

    membrances.

4. Rinse thoroughly and pat dry.

5. Discard cloth. Do not flush.

    If drying occurs, It may be controlled by rinsing cleanser off sooner or using 

    less often.


Precautions: See Package insert for complete Precautions and Prescribing information. For external use only.

Avoid contat with eyes, eyelids, lips ad mucous membranes. If accidental contact occurs, rinse with water, Contact with any colored material (Including hair and fabric) may result in bleaching or discoloration. If excessive irritation develops, discontinue use and consult your physician.


WARNINGS: Keep out of reach of children. When using this product, avoid unnecessary sun exposure and use a sunscreen.

Store at 15 Degree - 25 Degree Centigrade (59 Degree - 77 Degree F).


All prescription substitutions and/or recommendations using this product shall be made subject to state and federal statutes as applicable. NOTE: This is not an Orange Book product and has not been subjected to FDA therapeutic equivalency or other equivalency testing. No representation is made as to generic status or bioequivalency. Please see package insert for more information.


MANUFACTURED FOR: Acella Pharmaceuticals, LLC

Alpharetta, GA 30009

1-800-541-4802

Rx Only


60 foaming cloths - Net weight 3.2 g each


Acella

Pharmaceuticals, LLC


NDC 42192-128-60


BPO 9% Foaming Cloths


Contents: benzoyl peroxide USP 9% as an active ingredient in a cream vehicle containing cetostearyl alcohol, hydrogenated castor oil, cocamidopropyl betaine, PEG-14M, methyl paraben, mineral oil, purified water, sodium lauryl sulfate, potassium choride, glycolic acid, imidurea, sodium PCA liquid, cornstarch, titanium dioxide, sodium hydroxide, glycerine, dimethyl isosorbide.


Directions: Wash affecte areas with BPO 9% Foaming cloths once or twice daily, or as directed by your physician.

1. Wet face with water.

2. Wet cloth with a little water and work into a full lather.

3. Cleanse face wuth cloth for 10 - 20 seconds, avoiding eyes and mucous 

    membrances.

4. Rinse thoroughly and pat dry.

5. Discard cloth. Do not flush.

    If drying occurs, It may be controlled by rinsing cleanser off sooner or using  

    less often.


Precautions: See Package insert for complete Precautions and Prescribing information. For external use only.

Avoid contat with eyes, eyelids, lips ad mucous membranes. If accidental contact occurs, rinse with water, Contact with any colored material (Including hair and fabric) may result in bleaching or discoloration. If excessive irritation develops, discontinue use and consult your physician.


Warnings: KEEP OUT OF REACH OF CHILDREN. When using this product, avoid unnecessary sun exposure and use a sunscreen.

Store at 15 degree - 25 degree Centigrade (59 degree - 77 degree F).

NDC 42192-128-60


BPO 9% Foaming Cloths


Rx Only


60 foaming cloths - Net weight 3.2 g each


Acella

PHARMACEUTICALS, LLC


All prescription substitutions and/or recommendations using this product shall be made subject to state and federal statutes as applicable. NOTE: This is not an Orange Book product. No representation is made as to generic status or bioequivalency. Please see package insert for more information.


MANUFACTURED FOR:

Acella Pharmaceuticals, LLC

9005 Westside Parkway

Alpharetta, GA 30009

1-800-541-4802

Rev.0510v1

BPO 9 FOAMING  benzoyl peroxide  cloth

Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 42192-128 Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength BENZOYL PEROXIDE (BENZOYL PEROXIDE) BENZOYL PEROXIDE 9 g  in 100 g

Inactive Ingredients Ingredient Name Strength CETOSTEARYL ALCOHOL   HYDROGENATED CASTOR OIL   COCAMIDOPROPYL BETAINE   METHYLPARABEN   MINERAL OIL   WATER   SODIUM LAURYL SULFATE   GLYCOLIC ACID   IMIDUREA   SODIUM PYRROLIDONE CARBOXYLATE   TITANIUM DIOXIDE   SODIUM HYDROXIDE   DIMETHYL ISOSORBIDE

Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains

Packaging # NDC Package Description Multilevel Packaging 1 42192-128-60 60 PACKET In 1 CARTON contains a PACKET 1 3.2 g In 1 PACKET This package is contained within the CARTON (42192-128-60)

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		08/18/2010

Labeler - Acella Pharmaceuticals, LLC (825380939)

Revised: 12/2010Acella Pharmaceuticals, LLC

More BPO 9 Foaming Cloths resources

• BPO 9 Foaming Cloths Side Effects (in more detail)
• BPO 9 Foaming Cloths Use in Pregnancy & Breastfeeding
• BPO 9 Foaming Cloths Drug Interactions
• 0 Reviews for BPO 9ing Cloths - Add your own review/rating

Compare BPO 9 Foaming Cloths with other medications

• Acne
• Perioral Dermatitis

Cystadane

In the US, CYSTADANE (betaine systemic) is a member of the drug class nutraceutical products and is used to treat Nonalcoholic Fatty Liver Disease.

US matches:

• Cystadane Powder


• Cystadane

Ingredient matches for CYSTADANE

Betaine

Betaine is reported as an ingredient of CYSTADANE in the following countries:

• Australia


• Austria


• Belgium


• Denmark


• Germany


• Italy


• Spain


• Sweden


• United States

Betaine hydrochloride (a derivative of Betaine) is reported as an ingredient of CYSTADANE in the following countries:

• France


• Netherlands

International Drug Name Search

Demadex Solution

Pronunciation: TORE-se-mide
Generic Name: Torsemide
Brand Name: Generic only. No brands available.

Demadex Solution is used for:

Treatment of edema (swelling) associated with heart, kidney, or liver failure, or conditions in which there is excess body water. The injection is used when a rapid decrease of swelling is desired or when a tablet cannot be taken. It is also used alone or with other medicines to treat high blood pressure. It may also be used to treat certain conditions as determined by your doctor.

Demadex Solution is a loop diuretic. It works by making the kidneys eliminate larger amounts of electrolytes (especially sodium and potassium salts) and water than normal (diuretic effect).

Do NOT use Demadex Solution if:

• you are allergic to any ingredient in Demadex Solution or to a sulfonylurea (eg, glyburide)


• you are unable to urinate

Contact your doctor or health care provider right away if any of these apply to you.

Before using Demadex Solution:

Some medical conditions may interact with Demadex Solution. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have fluid in your abdomen, hearing impairment, diabetes mellitus, low urine output, high blood uric acid levels, a blood disorder, kidney disease, lupus, liver disease, or heart failure


• if you have had a heart attack


• if you are dehydrated

Some MEDICINES MAY INTERACT with Demadex Solution. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Aminoglycosides (eg, gentamicin) or cisplatin because the risk of temporary or permanent hearing loss may be increased


• Nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen, indomethacin) or probenecid because they may decrease Demadex Solution's effectiveness


• Chloral hydrate, digitalis (eg, digoxin), lithium, or suramin because the risk of their side effects may be increased by Demadex Solution

This may not be a complete list of all interactions that may occur. Ask your health care provider if Demadex Solution may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Demadex Solution:

Use Demadex Solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Demadex Solution is usually given as an injection at your doctor's office, hospital, or clinic.


• Do not use Demadex Solution if it contains particles, is cloudy or discolored, or if the vial is cracked or damaged.


• Demadex Solution should be given intravenously slowly over a period of at least 2 minutes or as a continuous infusion.


• Demadex Solution may increase the amount of urine or cause you to urinate more often when you first start taking it. To keep this from disturbing your sleep, try to take your dose before 6 pm.


• Avoid eating licorice or Korean ginseng while taking Demadex Solution.


• Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.


• If you miss a dose of Demadex Solution, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Demadex Solution.

Important safety information:

• Demadex Solution may cause dizziness. This effect may be worse if you take it with alcohol or certain medicines. Use Demadex Solution with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Demadex Solution may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.


• Patients who take medicine for high blood pressure often feel tired or run down for a few weeks after starting treatment. Be sure to take your medicine even if you may not feel "normal." Tell your doctor if you develop any new symptoms.


• Tell your doctor or dentist that you take Demadex Solution before you receive any medical or dental care, emergency care, or surgery.


• Demadex Solution may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Demadex Solution. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.


• Your doctor may have also prescribed a potassium supplement for you. If so, follow the dosing carefully. Do not start taking additional potassium on your own or change your diet to include more potassium without first checking with your doctor.


• Demadex Solution is a strong "water pill" (diuretic). Using too much of Demadex Solution can lead to serious water and mineral loss. Therefore, it is important that you be monitored by your doctor. Promptly notify your doctor if you become very thirsty, have a dry mouth, become confused, or develop muscle cramps/weakness.


• Diabetes patients - Demadex Solution may affect your blood sugar. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.


• Weight should be monitored while taking this medication.


• Lab tests, including kidney function, electrolyte levels, and blood pressure, may be performed while you use Demadex Solution. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Demadex Solution is not recommended for use in CHILDREN; safety and effectiveness in children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Demadex Solution while you are pregnant. It is not known if Demadex Solution is found in breast milk. If you are or will be breast-feeding while you use Demadex Solution, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Demadex Solution:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; dizziness or lightheadedness when sitting up or standing; excessive urination; headache; increased cough; nasal inflammation; nausea.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; diarrhea; dry mouth or unusual thirst; fever, chills, or persistent sore throat; hearing loss or ringing in the ears; loss of appetite; muscle pain or cramps; rapid or irregular heartbeat; rectal bleeding; red, swollen, blistered, or peeling skin; restlessness; unusual bruising or bleeding; unusual tiredness or weakness; vomiting.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Demadex side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include confusion; dizziness; dizziness or lightheadedness when sitting up or standing; dry mouth; excessive urination followed by a decrease in amount of urine, muscle cramps, weakness, and/or rapid or irregular heartbeat.

Proper storage of Demadex Solution:

Store Demadex Solution at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Do not freeze. Store away from heat, moisture, and light. Keep Demadex Solution out of the reach of children and away from pets.

General information:

• If you have any questions about Demadex Solution, please talk with your doctor, pharmacist, or other health care provider.


• Demadex Solution is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Demadex Solution. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Demadex resources

• Demadex Side Effects (in more detail)
• Demadex Use in Pregnancy & Breastfeeding
• Drug Images
• Demadex Drug Interactions
• Demadex Support Group
• 0 Reviews for Demadex - Add your own review/rating

Compare Demadex with other medications

• Ascites
• Edema
• Heart Failure
• High Blood Pressure
• Nonobstructive Oliguria
• Renal Failure

Rozex Emulsion

Pronunciation: me-troe-NIH-duh-zole
Generic Name: Metronidazole
Brand Name: Rozex

Rozex Emulsion is used for:

Treating redness and inflammation associated with the skin disorder rosacea. It also may be used for other conditions as determined by your doctor.

Rozex Emulsion is an oral antiprotozoal and antibacterial. It is thought to work by entering the bacterial cell, acting on some components of the cell and destroying the bacteria.

Do NOT use Rozex Emulsion if:

• you are allergic to any ingredient in Rozex Emulsion


• you are taking an ergot alkaloid (eg, ergotamine) or disulfiram


• you are taking an HIV protease inhibitor that contains alcohol (eg, ritonavir); check with your pharmacist if you are unsure if the medicine contains alcohol


• you drink alcohol

Contact your doctor or health care provider right away if any of these apply to you.

Before using Rozex Emulsion:

Some medical conditions may interact with Rozex Emulsion. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a central nervous system disease

Some MEDICINES MAY INTERACT with Rozex Emulsion. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Barbiturates (eg, phenobarbital) because they may decrease Rozex Emulsion's effectiveness


• Aminoquinolines (eg, chloroquine), anticoagulants (eg, warfarin), busulfan, carbamazepine, cyclosporine, disulfiram, ergot alkaloids (eg, ergotamine), ethanol, fluorouracil, HIV protease inhibitors containing alcohol (eg, ritonavir), imatinib, lithium, macrolide immunosuppressants (eg, tacrolimus), or mitomycin because the risk of their side effects may be increased by Rozex Emulsion


• Amphotericin B or oral contraceptives (eg, birth control pills) because their effectiveness may be decreased by Rozex Emulsion

This may not be a complete list of all interactions that may occur. Ask your health care provider if Rozex Emulsion may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Rozex Emulsion:

Use Rozex Emulsion as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Wash and completely dry the affected area.


• Apply a thin layer of Rozex Emulsion to the affected area. Gently rub the medicine in until it is evenly distributed.


• Makeup may be applied after using Rozex Emulsion.


• Rozex Emulsion works best if it is taken at the same time each day.


• To clear up your infection completely, use Rozex Emulsion for the full course of treatment. Keep using it even if you feel better in a few days.


• Continue to use Rozex Emulsion even if you feel well. Do not miss any doses.


• If you miss a dose of Rozex Emulsion, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Rozex Emulsion.

Important safety information:

• Rozex Emulsion in for external use only. Avoid getting Rozex Emulsion in your eyes or on the inside of your nose or mouth.


• Do not drink alcohol while you are using Rozex Emulsion and for at least 3 days after the last dose.


• Contact your doctor right away if stomach pain or cramps, severe diarrhea, or bloody stools occur. Do not treat diarrhea without first checking with your doctor.


• Be sure to use Rozex Emulsion for the full course of treatment. If you do not, the medicine may not clear up your infection completely. The bacteria could also become less sensitive to this or other medicines. This could make the infection harder to treat in the future.


• Long-term or repeated use of Rozex Emulsion may cause a second infection. Tell your doctor if signs of a second infection occur. Your medicine may need to be changed to treat this.


• Rozex Emulsion should not be used in CHILDREN; safety and effectiveness in children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Rozex Emulsion while you are pregnant. Rozex Emulsion is found in breast milk. If you are or will be breast-feeding while you use Rozex Emulsion, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Rozex Emulsion:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Burning; itching; mild dryness; redness; skin irritation; stinging.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bloody stools; diarrhea; nausea; stomach pain/cramps; tingling or numbness in hands and feet.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Rozex side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Rozex Emulsion may be harmful if swallowed.

Proper storage of Rozex Emulsion:

Store Rozex Emulsion at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Rozex Emulsion out of the reach of children and away from pets.

General information:

• If you have any questions about Rozex Emulsion, please talk with your doctor, pharmacist, or other health care provider.


• Rozex Emulsion is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Rozex Emulsion. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Rozex resources

• Rozex Side Effects (in more detail)
• Rozex Use in Pregnancy & Breastfeeding
• Rozex Drug Interactions
• Rozex Support Group
• 0 Reviews for Rozex - Add your own review/rating

Compare Rozex with other medications

• Perioral Dermatitis
• Rosacea

Donepezil Pliva

Donepezil Pliva may be available in the countries listed below.

Ingredient matches for Donepezil Pliva

Donepezil

Donepezil hydrochloride (a derivative of Donepezil) is reported as an ingredient of Donepezil Pliva in the following countries:

• Croatia (Hrvatska)

International Drug Name Search

Grinolart

Grinolart may be available in the countries listed below.

Ingredient matches for Grinolart

Tiapride

Tiapride hydrochloride (a derivative of Tiapride) is reported as an ingredient of Grinolart in the following countries:

• Japan

International Drug Name Search

Mustargen

Mustargen is a brand name of mechlorethamine, approved by the FDA in the following formulation(s):

MUSTARGEN (mechlorethamine hydrochloride - injectable; injection)

• 
  Manufacturer: LUNDBECK INC
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 10MG/VIAL ^[RLD]

Has a generic version of Mustargen been approved?

No. There is currently no therapeutically equivalent version of Mustargen available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Mustargen. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Mustargen.

See also...

• Mustargen Consumer Information (Wolters Kluwer)
• Mustargen Consumer Information (Cerner Multum)
• Mustargen Advanced Consumer Information (Micromedex)
• Mechlorethamine Consumer Information (Wolters Kluwer)
• Mechlorethamine Consumer Information (Cerner Multum)
• Mechlorethamine Intravenous Advanced Consumer Information (Micromedex)
• Mechlorethamine Topical Advanced Consumer Information (Micromedex)

Lipitor Lyfjaver

Lipitor Lyfjaver may be available in the countries listed below.

Ingredient matches for Lipitor Lyfjaver

Atorvastatin

Atorvastatin calcium (a derivative of Atorvastatin) is reported as an ingredient of Lipitor Lyfjaver in the following countries:

• Iceland

International Drug Name Search

Trol

Trol may be available in the countries listed below.

Ingredient matches for Trol

Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Trol in the following countries:

• Bangladesh

International Drug Name Search

Carvedilol Spirig

Carvedilol Spirig may be available in the countries listed below.

Ingredient matches for Carvedilol Spirig

Carvedilol

Carvedilol is reported as an ingredient of Carvedilol Spirig in the following countries:

• Switzerland

International Drug Name Search

Nufaclav

Nufaclav may be available in the countries listed below.

Ingredient matches for Nufaclav

Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Nufaclav in the following countries:

• Indonesia

Clavulanate

Clavulanic Acid is reported as an ingredient of Nufaclav in the following countries:

• Indonesia

International Drug Name Search

Franol

Franol may be available in the countries listed below.

Ingredient matches for Franol

Theophylline

Theophylline is reported as an ingredient of Franol in the following countries:

• Brazil


• Thailand

International Drug Name Search

Doxazosina Alter

Doxazosina Alter may be available in the countries listed below.

Ingredient matches for Doxazosina Alter

Doxazosin

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Doxazosina Alter in the following countries:

• Italy


• Spain

International Drug Name Search

Nitroglicerina

Nitroglicerina may be available in the countries listed below.

Ingredient matches for Nitroglicerina

Nitroglycerin

Nitroglycerin is reported as an ingredient of Nitroglicerina in the following countries:

• Chile


• Colombia


• Peru


• Venezuela

International Drug Name Search

Plaunac

Plaunac may be available in the countries listed below.

Ingredient matches for Plaunac

Olmesartan

Olmesartan Medoxomil is reported as an ingredient of Plaunac in the following countries:

• Italy

International Drug Name Search

Para-G

Para-G may be available in the countries listed below.

Ingredient matches for Para-G

Paracetamol

Paracetamol is reported as an ingredient of Para-G in the following countries:

• Myanmar

International Drug Name Search

Dermosporin

Dermosporin may be available in the countries listed below.

Ingredient matches for Dermosporin

Clotrimazole

Clotrimazole is reported as an ingredient of Dermosporin in the following countries:

• Sri Lanka

International Drug Name Search

Ginera

Ginera may be available in the countries listed below.

Ingredient matches for Ginera

Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Ginera in the following countries:

• Turkey

Gestodene

Gestodene is reported as an ingredient of Ginera in the following countries:

• Turkey

International Drug Name Search

Nor glucox

Nor glucox may be available in the countries listed below.

Ingredient matches for Nor glucox

Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Nor glucox in the following countries:

• El Salvador

International Drug Name Search

Alli

In the US, Alli (orlistat systemic) is a member of the drug class peripherally acting antiobesity agents and is used to treat Obesity.

US matches:

• Alli

UK matches:

• alli 60 mg hard capsules (SPC)

Ingredient matches for Alli

Orlistat

Orlistat is reported as an ingredient of Alli in the following countries:

• Austria


• Finland


• France


• Germany


• Greece


• Luxembourg


• Sweden


• Switzerland


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Nifluril Oint

Nifluril Oint may be available in the countries listed below.

Ingredient matches for Nifluril Oint

Niflumic Acid

Niflumic Acid is reported as an ingredient of Nifluril Oint in the following countries:

• Taiwan

International Drug Name Search

Mekitazenon

Mekitazenon may be available in the countries listed below.

Ingredient matches for Mekitazenon

Mequitazine

Mequitazine is reported as an ingredient of Mekitazenon in the following countries:

• Japan

International Drug Name Search

Aminofillina Biologici

Aminofillina Biologici may be available in the countries listed below.

Ingredient matches for Aminofillina Biologici

Aminophylline

Aminophylline is reported as an ingredient of Aminofillina Biologici in the following countries:

• Italy

International Drug Name Search

Neoanalginas

Neoanalginas may be available in the countries listed below.

Ingredient matches for Neoanalginas

Metamizole

Metamizole sodium anhydrous (a derivative of Metamizole) is reported as an ingredient of Neoanalginas in the following countries:

• Lithuania

International Drug Name Search

Gentamicina Sulfato Sanderson

Gentamicina Sulfato Sanderson may be available in the countries listed below.

Ingredient matches for Gentamicina Sulfato Sanderson

Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Gentamicina Sulfato Sanderson in the following countries:

• Peru

International Drug Name Search

Robaxin-750

See also: Generic Robaxin

Robaxin-750 is a brand name of methocarbamol, approved by the FDA in the following formulation(s):

ROBAXIN-750 (methocarbamol - tablet; oral)

• 
  Manufacturer: SCHWARZ PHARMA
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 750MG ^[RLD][AA]

Has a generic version of Robaxin-750 been approved?

Yes. The following products are equivalent to Robaxin-750:

methocarbamol tablet; oral

• 
  Manufacturer: AUSTARPHARMA LLC
  
  Approval date: October 21, 2011
  
  Strength(s): 750MG ^[AA]


• 
  Manufacturer: HETERO DRUGS
  
  Approval date: November 6, 2009
  
  Strength(s): 750MG ^[AA]


• 
  Manufacturer: LANNETT HOLDINGS INC
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 750MG ^[AA]


• 
  Manufacturer: SANDOZ
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 750MG ^[AA]


• 
  Manufacturer: VINTAGE PHARMS
  
  Approval date: January 29, 2003
  
  Strength(s): 750MG ^[AA]


• 
  Manufacturer: WATSON LABS
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 750MG ^[AA], 750MG ^[AA]


• 
  Manufacturer: WEST WARD
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 750MG ^[AA]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Robaxin-750. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Robaxin-750.

See also...

• Robaxin-750 Consumer Information (Cerner Multum)
• Robaxin-750 Advanced Consumer Information (Micromedex)
• Methocarbamol Consumer Information (Drugs.com)
• Methocarbamol Consumer Information (Wolters Kluwer)
• Methocarbamol Tablets Consumer Information (Wolters Kluwer)
• Methocarbamol Consumer Information (Cerner Multum)
• Methocarbamol Advanced Consumer Information (Micromedex)
• Methocarbamol Injection Advanced Consumer Information (Micromedex)
• Methocarbamol AHFS DI Monographs (ASHP)